Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chow, B.
Right arrow Articles by Bion, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, B.
Right arrow Articles by Bion, J. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2000, Vol. 85, No. 6 850-855
© 2000 The Board of Management and Trustees of the British Journal of Anaesthesia

Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation{dagger}

B. Chow1, M. I. Bowden1, E. Ho1, B. C. Weatherley2 and J. F. Bion1

1University Department of Anaesthesia and Intensive Care Medicine, N5 Queen Elizabeth Hospital, Birmingham B15 2TH, UK. 2Classical & Bayesian Solutions, Orpington, Kent BR6 0EP, UK*Corresponding author

{dagger}This paper was presented in abstract form at the Anaesthetic Research Society in Birmingham on July 11, 1996.

We examined the pharmacokinetics and pharmacodynamics of atracurium besylate and its metabolites in children after orthotopic liver transplantation (OLT), as a suitable model for critically ill children. Ten children were studied after OLT on return to the intensive care unit (ICU). The mean (range) age was 36 (7–78) months, and weight 6–24.2 kg. Atracurium was started at induction of anaesthesia and adjusted in the ICU according to clinical need. Neuromuscular block was measured using accelerometry (TOFguard) and the train-of-four (TOF) ratio or count. Arterial plasma samples for atracurium and metabolites taken before, 12-hourly during, and at frequent intervals after the infusion were analysed by HPLC. The mean (range) maximum infusion rate during steady-state conditions was 1.44 (0.48–3.13) mg kg–1 h–1 and the duration of infusion 36.9 (22.5–98.4) h. Tachyphylaxis was not observed. The mean terminal half-life (t1/2) for atracurium was 18.8 (12–32.3) min. The steady-state plasma clearance (CLss) was 13.9 (7.9–20.3) ml min–1 kg–1 and the terminal volume of distribution (VZ) 390 (124–551) ml kg–1; both were higher than in adults after successful OLT. The maximum concentration (Cmax) of laudanosine was 1190 (400–1890) ng ml–1 and t1/2 was 3.9 (1.1–6.7) h. The renal clearance of laudanosine was 0.9 (0.1–2.5) ml min–1 kg–1 and increased with urine flow, but there was no significant relationship with serum creatinine. EEG spikes were confirmed in one child only; the corresponding laudanosine Cmax was 720 ng ml–1. Monoquaternary alcohol Cmax was 986 (330–1770) ng ml–1 and t1/2 42.9 (30–57.7) min. Mean recovery time on stopping the atracurium infusion to a TOF ratio >0.75 was 23.6 (12–27) min. Atracurium is an effective and safe neuromuscular blocking agent in this population. Laudanosine concentrations are not excessive if graft function is satisfactory.

Br J Anaesth 2000; 85: 850–5


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.